Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

Similar documents
Investigating rare diseases with Agilent NGS solutions

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Genomic structural variation

CHROMOSOMAL MICROARRAY (CGH+SNP)

Genomic complexity and arrays in CLL. Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy

Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Prenatal Diagnosis: Are There Microarrays in Your Future?

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

CNV Detection and Interpretation in Genomic Data

Back to the Basics: Methyl-Seq 101

Structural Variation and Medical Genomics

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology

Agilent s Copy Number Variation (CNV) Portfolio

The role of cytogenomics in the diagnostic work-up of Chronic Lymphocytic Leukaemia

CYTOGENETICS Dr. Mary Ann Perle

Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads

Genetic Counselling in relation to genetic testing

An Overview of Cytogenetics. Bridget Herschap, M.D. 9/23/2013

Supplementary note: Comparison of deletion variants identified in this study and four earlier studies

Determination of Genomic Imbalances by Genome-wide Screening Approaches

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit

NEW YORK STATE DEPARTMENT OF HEALTH CLINICAL LABORATORY EVALUATION PROGRAM. Crosswalk of Proposed Revisions to Cytogenetics Standards

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Corporate Medical Policy

Chromosome Abnormalities

DNA-seq Bioinformatics Analysis: Copy Number Variation

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray

Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

Oncology Genetics: Cytogenetics and FISH 17/09/2014

What s the Human Genome Project Got to Do with Developmental Disabilities?

LIST OF INVESTIGATIONS

SEAMLESS CGH DIAGNOSTIC TESTING

Genetic Testing for Single-Gene and Multifactorial Conditions

Sharan Goobie, MD, MSc, FRCPC

ACMG/CAP Cytogenetics CY

Chromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases

CLL Complete SM Report

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

FONS Nové sekvenační technologie vklinickédiagnostice?

CNV detection. Introduction and detection in NGS data. G. Demidov 1,2. NGSchool2016. Centre for Genomic Regulation. CNV detection. G.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

Understanding DNA Copy Number Data

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

MEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG)

PROVIDER POLICIES & PROCEDURES

Vega: Variational Segmentation for Copy Number Detection

Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?

Genetics update and implications for (General) Practice

Understanding The Genetics of Diamond Blackfan Anemia

Clinical Genomics. Ina E. Amarillo, PhD FACMGG

Global variation in copy number in the human genome

Molecular Aspects of Melanocytic Neoplasia. Iwei Yeh MD, PhD University of California, San Francisco

PG-Seq NGS Kit for Preimplantation Genetic Screening

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Genetic Testing Methods

No mutations were identified.

SALSA MLPA probemix P315-B1 EGFR

Role of FISH in Hematological Cancers

scfish: A Primer Peter K. Rogan, Ph.D. Joan H. M. Knoll, Ph.D., FACMG, FCCMG Children s Mercy Hospitals and Clinics Tuesday, July 29, 2003

Reporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota

Cytogenetics Technologies, Companies & Markets

Nature Biotechnology: doi: /nbt.1904

Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks?

MPS for translocations

UNIVERSITI TEKNOLOGI MARA COPY NUMBER VARIATIONS OF ORANG ASLI (NEGRITO) FROM PENINSULAR MALAYSIA

Workflow. Connecting the Pieces For Total Patient Care

Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

An International System for Human Cytogenetic Nomenclature (2013)

Human Genetic Variation Copy Number Variation

Using the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

Dako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis)

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray

Benefits and pitfalls of new genetic tests

Genetics Quality and Accreditation workshop Manchester 17 th May 2017

Non-Profit Startup Paradigm Launches Cancer Panel Based on DNA, RNA Sequencing

Identification of genomic alterations in cervical cancer biopsies by exome sequencing

Same Day, Cost-Effective Aneuploidy Detection with Agilent Oligonucleotide array CGH and MDA Single Cell Amplification Method

MRC-Holland MLPA. Description version 08; 30 March 2015

Performance Characteristics BRCA MASTR Plus Dx

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Clinical Interpretation of Cancer Genomes

Genomic Medicine: What every pathologist needs to know

Collected: , PM Sent: , PM Received: , PM Preliminary: , PM. Notification Status: COMPREHENSIVE DIAGNOSIS

Diagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening

Phylogenomics. Antonis Rokas Department of Biological Sciences Vanderbilt University.

Transcription:

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these work together? 2

Classical Cytogenetic Analysis S1 CAG EMEAI Agilent Restricted Page 33

Technology Advancements: Smaller Aberrations 3-5Mb 50-100kb 5-10Mb 0.5Mb >60bp 1bp 4

Technology Advancements: CGH vs Karyotype 1Mb Deletion Li and Andersson: J Pediatr. 2009 Sep;155(3):311-7. 5

Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these work together? 6

How does it work? Small fragments of DNA from known regions of each chromosome are arrayed onto glass microscope slides.

Three Agilent platform technologies for molecular analysis SurePrint CGH+SNP microarrays SureFISH HaloPlex based on OLS (Oligo Library Synthesis)

Typical Microarray Workflow Sample Nucleic Acid Purification Sample QC Labeling Hybridization Scanning Data Analysis Page 9

Sample types used in clinical CGH research CANCER Postnatal PRENATAL Blood Bone marrow Solid tumor: Frozen FFPE Blood Saliva Amniotic Fluid Chorionic Villus Sampling POC Page 10

CGH Data Interpretation Trisomy 21 11

Technology Advancements: CGH vs. Karyotype Miller el. al. Amer J. Human Genet 86, 749 764, May 14, 2010 749 12

acgh Detects Net Copy Changes Page 13

Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these work together? 14

What is F.I.S.H? FISH uses fluorescent molecules to paint genes or chromosomes. Involves the use of short single stranded sequences of DNA which are labeled with fluorescent tags to bind to the complimentary sequence of DNA

SureFISH Detection of Smaller Regions: confirming the acgh results Repeat Gaps Red : SureFISH probe Green: BAC CEP c-met locus divided into 6 regions Region Size (kb) Sequence Tiled (kb) 1 23.3 14.1 2 20.0 14.1 3 27.9 14.1 4 27.6 14.1 5 31.4 14.1 6 23.6 13.6 1 2 3 4 Region 4 5 6 Regions 1-6 20/20 metaphase and 20/20 interphase cells showed this staining

Pros of FISH Rapid results, ~5 days (STAT case-24hrs) High efficiency of hybridization and detection Lots of cells can be analyzed Cells do not need to be actively dividing

Cons of FISH Not a Global test Dependant on lateral testing Validation of new probes is time consuming and requires a lot of tech time.

Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these work together? 20

What is Next-Gen Sequencing: Brief History Frederick Sanger (Sanger Sequencing) First Generation (circa 1977) Radiolabeled Nucleotides (Sequencing Gels) Automated Capillary Electrophoresis Second Generation ABI 370 (500 Kb/day) ABI3730 (2.8 Mb/day) Helped drive the Human Genome Project Massively Parallel Sequencing Next-Generation Sequencing Does not use Sanger method High throughput with reduced cost Capable of Outputting >100 Gb/day! Desktop Sequencers & Beyond! Next-Next-Generation Sequencing 21

Target Enrichment: It s just like fishing What is the concept? 1. Use oligos (i.e. baits) that are complementary to genomic regions of interest (i.e. ROI s) 2. Baits will specifically catch (i.e. hybridize) to the ROI s 3. Regions that are caught get sequenced, the rest is washed away Why do it? 1. Sequence only your regions of interest! 2. Focus on a smaller subset 3. Sequence more samples per run (i.e. Multiplex) 4. Save time and money 5. Faster time to data 6. Identify variants in samples with increased reliability and accuracy

Technology Advancements: CGH vs. Next Gen Sequencing Publications have explored WGS for CNAs as well as Exome Capture Detection of CNAs using targeted exome capture sequencing in cancer 17 prostate tumor-normal pairs (SSEL 38Mb vs. Agilent 244k CGH) Data sets highly concordant Lonigro et al. Neoplasia Vol13(11) 2011, pp.1019-1025. 23

SAT Analogy Question Karyotyping : FISH okaryotyping : acgh oacgh : NGS ofish : NGS okaryotyping : r-banding

SAT Analogy Question Karyotyping : FISH okaryotyping : acgh oacgh : NGS ofish : NGS okaryotyping : r-banding

Current Benefits of acgh over NGS for CNAs Well-established workflow and simple analysis Ability to detect exonlevel resolution, LOH, low-level mosaicism Decipher complex rearrangements Leverage data already generated by international consortia Cy5 Cy3 Red Green Exp Ref Amp Del -3-2 -1 0 +1 +2 +3 Lower cost and higher throughput for acgh compared to NGS acgh Source: Frederick National Laboratory for Cancer Research NGS 26

Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these work together? 27

Applications: Targeted Cancer Panels Aim: To evaluate acgh as cost-effective alternative to multi-probe FISH for profiling and risk stratification in CLL Mapping 13q14 deletions in 41 cases Method: 62 CLL samples (pilot) followed by 38 blinded samples (>25% CLL) to compare w/ FISH and/or, G-banding karyotype Agilent custom 4x44k array genome-wide coverage w/ high density in 15 CLL target regions Journal Mol.Diagnostics, Vol. 11(5): January 2009 28

Applications: Targeted Cancer Panels 29

Applications: Low-level Mosaicism Aim: To identify the 10-15% missing alterations in EXT mutation-negative Multiple osteochondroma (MO) cases. Method: Custom 4x44k CGH array, tiling EXT1, EXT2 and 68 candidate genes Screen 17 patients with previously undetected mutations to identify other causative aberrations Results: Somatic mosaicism in EXT genes in 3 previously negative cases. Aberrations detected at 10-15% mosaicism. Hum. Mutat., 32: E2036 E2049. doi: 10.1002/humu.21423

Challenges: Complex Rearrangements Complex rearrangements can be detected by high resolution custom array that spans the MECP2 locus. The duplications and triplications are detected by arrays while inversion were detected by sequencing the break point. Duplication Triplication Inversion-Dup 31

Free Design Iteration

Free Design Iteration: CLL and GLI3 Mapping of 13q14 deletions in 41 CLL cases that had detectable deletions GLI3 Targeted CGH Array Journal Mol.Diagnostics, Vol. 11(1): January 2009 J Med Genet 2007 44 (1), e59 33

Free Design Iteration: Ch18 Array Heard P. et al. Am J Med Genet A. 2009 July; 149A(7): 1431 1437. 34

Free Design Iteration: Dystrophin gene del Gaudio D et al. Human Mutation 29(9),1100-1107,2008 35

Three Agilent platform technologies for molecular analysis SurePrint CGH+SNP microarrays SureFISH HaloPlex based on OLS (Oligo Library Synthesis)

Agilent HaloPlex is For Research Use Only. Not for use in Diagnostic Procedures." Agilent CGH+SNP Microarrays are For Research Use Only. Not for Use in Diagnostic Procedures. User is Responsible for US FDA Approval or Clearance Prior to Diagnostic Use. Agilent SureFISH probes are Analyte Specific Reagents. Analytical and performance characteristics are not established. 37

38 Thank you